ARTV Award Disclosure
Aslan Fred · SEC Form 4 · Filed Sep 14, 2026
Award
Calculated transaction value
$0
Aslan Fred Chief Executive Officer
ARTV
Transaction date
Sep 10, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 5 days later
ARTV daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 155,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-391012
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. ARTV | Award | Sep 10, 2026 | $0 |
| Artiva Biotherapeutics, Inc. ARTV Current | Award | Sep 10, 2026 | $0 |